25086857|t|Assessment of CSF Abeta42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies.
25086857|a|Mild Alzheimer's disease (AD) is usually difficult to differentiate from other dementias or mild cognitive impairment (MCI). The aim of our study is to evaluate the clinical importance of cerebrospinal fluid (CSF) beta-amyloid 42 (Abeta42) in MCI, AD and other dementias, more specifically: frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), Parkinson's disease (PD) with dementia (PDD) and vascular dementia (VaD). Fifty eligible articles were identified by search of databases including PubMed, EMBASE, Elsevier, Springer Link and the Cochrane Library, from January 1990 to May 2014. The random effects model was used to calculate the standardized mean difference (SMD) with corresponding 95% CI by STATA 9.0 software. The subgroup analyses were made on the method (ELISA, xMAP). We found that CSF Abeta42 concentrations were significantly lower in AD compared to MCI (SMD: -0.68, 95% CI: [-0.80, -0.56], z=11.34, P<0.001), FTD (SMD: -1.09, 95% CI: [-1.41, -0.76], z=6.62, P<0.001), PDD (SMD: -0.75, 95% CI: [-1.39, -0.10], z=2.27, P=0.023), VaD (SMD: -0.95, 95% CI: [-1.30, -0.61], z=5.43, P<0.001). In addition, compared to DLB, Abeta42 concentrations are moderately lower in AD (SMD: -0.27, 95% CI: [-0.51, -0.03], z=2.20, P=0.028). Results from this meta-analysis hinted that CSF Abeta42 is a good biomarker for discriminating Alzheimer's disease from other dementias and MCI.
25086857	18	25	Abeta42	Gene	351
25086857	54	73	Alzheimer's disease	Disease	MESH:D000544
25086857	85	94	dementias	Disease	MESH:D003704
25086857	104	124	cognitive impairment	Disease	MESH:D003072
25086857	162	181	Alzheimer's disease	Disease	MESH:D000544
25086857	183	185	AD	Disease	MESH:D000544
25086857	236	245	dementias	Disease	MESH:D003704
25086857	254	274	cognitive impairment	Disease	MESH:D003072
25086857	276	279	MCI	Disease	MESH:D060825
25086857	388	395	Abeta42	Gene	351
25086857	400	403	MCI	Disease	MESH:D060825
25086857	405	407	AD	Disease	MESH:D000544
25086857	418	427	dementias	Disease	MESH:D003704
25086857	448	471	frontotemporal dementia	Disease	MESH:D057180
25086857	473	476	FTD	Disease	MESH:D057180
25086857	479	504	dementia with Lewy bodies	Disease	MESH:D020961
25086857	506	509	DLB	Disease	MESH:D020961
25086857	512	531	Parkinson's disease	Disease	MESH:D010300
25086857	533	535	PD	Disease	MESH:D010300
25086857	542	550	dementia	Disease	MESH:D003704
25086857	552	555	PDD	Disease	MESH:D003966
25086857	561	578	vascular dementia	Disease	MESH:D015140
25086857	580	583	VaD	Disease	MESH:D015140
25086857	970	977	Abeta42	Gene	351
25086857	1021	1023	AD	Disease	MESH:D000544
25086857	1036	1039	MCI	Disease	MESH:D060825
25086857	1096	1099	FTD	Disease	MESH:D057180
25086857	1155	1158	PDD	Disease	MESH:D003966
25086857	1214	1217	VaD	Disease	MESH:D015140
25086857	1298	1301	DLB	Disease	MESH:D020961
25086857	1303	1310	Abeta42	Gene	351
25086857	1350	1352	AD	Disease	MESH:D000544
25086857	1456	1463	Abeta42	Gene	351
25086857	1503	1522	Alzheimer's disease	Disease	MESH:D000544
25086857	1534	1543	dementias	Disease	MESH:D003704
25086857	1548	1551	MCI	Disease	MESH:D060825
25086857	Association	MESH:D003072	351
25086857	Negative_Correlation	MESH:D000544	351

